Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
559,687
Value
$349.0M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026559,687$349.0M0.1%+46,627+9.1%AddedHolders
Q1 2026513,060$396.3M0.1%+13,516+2.7%AddedHolders
Q4 2025499,544$385.6M0.1%+448+0.1%AddedHolders
Q3 2025499,096$280.6M0.1%−20,341−3.9%ReducedHolders
Q2 2025519,437$272.7M0.1%−51,750−9.1%ReducedHolders
Q1 2025571,187$362.3M0.1%−15,838−2.7%ReducedHolders
Q4 2024587,025$418.1M0.1%+16,961+3.0%AddedHolders
Q3 2024570,064$599.2M0.1%−16,498−2.8%ReducedHolders
Q2 2024586,562$616.5M0.2%−2,391−0.4%ReducedHolders
Q1 2024588,953$566.9M0.2%−4,569−0.8%ReducedHolders
Q4 2023593,522$521.3M0.2%−25,744−4.2%ReducedHolders
Q3 2023619,266$509.7M0.2%+6,442+1.1%AddedHolders
Q2 2023612,824$440.3M0.1%−20,684−3.3%ReducedHolders
Q1 2023633,508$520.5M0.2%−1,080−0.2%ReducedHolders
Q4 2022634,588$457.8M0.2%−15,819−2.4%ReducedHolders
Q3 2022650,407$448.1M0.2%+18,501+2.9%AddedHolders
Q2 2022631,906$373.6M0.1%+46,757+8.0%AddedHolders
Q1 2022585,149$408.6M0.1%+82,651+16.4%AddedHolders
Q4 2021502,498$317.4M0.1%+98,968+24.5%AddedHolders
Q3 2021403,530$244.2M0.1%+83,276+26.0%AddedHolders
Q2 2021320,254$178.8M0.1%+70,107+28.0%AddedHolders
Q1 2021250,147$118.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.